Womens Health Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

1
Womens Health Market Global Industry Analysis,
Trends, Market Size and Forecasts up to 2024
2
The report on Womens Health Market by treatment
type (hormonal, non-hormonal), diseases
indication (hypothyroidism, osteoporosis,
uterine fibroid, cancer, post-menopausal
syndrome, contraceptive, urinary tract
infection), distribution channel (online,
hospital, retail pharmacy) trends analysis and
forecasts up to 2024 studies the market sizes,
key trends and opportunities in the main
geographies such as North America, Europe,
Asia-Pacific, Rest of the World. According to the
report the Global Womens Health Market is
projected to grow at a CAGR of 5.72 in terms of
value over the period of 2018-2024. The growth in
the world market is primarily driven by
significant contribution by North America
(Leading region) region to this market. Get a
Sample Request https//www.infiniumglobalresearch
.com/reports/sample_request/1142 Market
Insight A woman has unique health issues such as
pregnancy, menopause, and other diseases. The
innovations in prescription drugs for women
health are used to treat a number of diseases and
conditions in a variety of therapeutic areas.
According to Health, about 52.3 of women in age
of 50 to 59 suffer from menopause uses
antidepressant therapy. Growing female elderly
population, unhealthy lifestyle, satisfactory
government strategies initiatives by private
organizations are some of the drivers that boost
the market. Research and development for
innovation of new medicines for women is likely
to surge this market. Additionally increasing
awareness among society about the availability of
treatment for womens health related diseases
propel the growth of this market.Moreover,
improving healthcare organization in emerging
markets and rising number of government
approvals for immunoassay techniques provide
substantial growth opportunities for key players
in the women health market.
3
Segment Covered The report on global women's
health market covers segments such as, treatment
type, diseases indication and distribution
channel. On the basis of treatment type the
global women's health market is categorized into
hormonal and non-hormonal. Combination therapy,
thyroid replacement therapy, estrogen therapy,
progestin therapy, parathyroid hormone therapy,
and others is sub segment of hormonal treatment
type. Cancer targeted therapy drugs,
antibiotics, bisphosphonates, and others are
included in non-hormonal treatment segment. On
the basis of diseases indication the global
women's health market is categorized into
hypothyroidism, osteoporosis, uterine fibroid,
cancer, post-menopausal syndrome, contraceptive,
urinary tract infection and others. On the basis
of distribution channel the global women's health
market is categorized into online pharmacy,
hospital pharmacy and retail pharmacy. Make an
Enquiry https//www.infiniumglobalresearch.com/re
ports/enquiry/1142 Geographic Coverage The
report provides regional analysis covering
geographies such as North America, Europe,
Asia-Pacific, and Rest of the World. In this
section the key trends and market size for each
geography is provided over the period of
2016-2024. The countries covered in the North
America region include the U.S., Canada, and
Mexico while Asia-Pacific includes China,
Japan, India, South Korea, Malaysia, and among
others. Moreover, Germany, U.K., France, Spain,
and Rest of Europe are included in the European
region. The U.S. drives the growth in the North
America region as it is the largest market in the
region. The Asia-pacific region offers a
substantial potential for the market growth
owing to rapid growth in markets such as India
and China. The APAC region is projected to
experience a growth at a CAGR of x.x over the
period of 2018-2024.
4
Companies Profiled The report provides profiles
of the companies in the global women's health
market such as, Novartis AG, Merck Co., Inc.,
Amgen Inc, Eli Lilly and Company, Lupin
Pharmaceuticals, Inc., Novo Nordisk A/S,
AstraZeneca, Pfizer, Inc., Sanofi and Other. This
industry feature for merger and acquision as an
explanations strategy for instance
Ahmedabad-based Torrent Pharma has completed the
acquisition of women healthcare brands
Regestrone and Pregachieve for India from Swiss
pharma major Novartis AG. Click the Below Full
Report Link https//www.infiniumglobalresearch.co
m/healthcare_medical_devices/global_womens_health_
market Report Highlights The report provides
deep insights on demand forecasts, market trends
and micro and macro indicators. In addition,
this report provides insights on the factors that
are driving and restraining the global women's
health market. Moreover, IGR-Growth Matrix
analysis given in the report brings an insight on
the investment areas that existing or new market
players can consider. The report provides
insights into the market using analytical tools
such as Porter's five forces analysis and DRO
analysis of women's health market. Moreover, the
study highlights current market trends and
provides forecast from 2018-2024. We also have
highlighted future trends in the women's health
market that will impact the demand during the
forecast period. Moreover, the competitive
analysis given in each regional market brings an
insight on the market share of the leading
players. This report will help manufacturers,
suppliers and distributors of the women's health
market to understand the present and future
trends in this market and formulate their
strategies accordingly.